NDRA - Why ENDRA Life Sciences Stock Is Down 65% | Benzinga
ENDRA Life Sciences Inc (NASDAQ:NDRA) shares are trading lower by some 65% to $0.07 during Tuesday’s session. The company priced a public offering of 61,538,461 shares of common stock (or pre-funded warrants in lieu of shares) with accompanying Series A and Series B warrants. This offering is a “best-efforts” format, so there’s no guaranteed amount of money raised.
ENDRA intends to use the net proceeds from this offering for general business purposes, which may include funding daily operations and ongoing development of their technology. The offering is expected to close by tomorrow, June 5th.
See ...